- Acute and 28-days subacute toxicity studies of Gαq-RGS2 signaling inhibitor
-
Beladiya JV, Mehta AA
- KMID: 2521034
- Lab Anim Res.
- 2021 Sep;37(3):193-202.
- doi: 10.1186/s42826-021-00093-1
Background: The aim of study was to evaluate the single oral dose and 28 day repeated oral administration toxicity profile of the synthetic compound Gαq-RGS2 signaling inhibitor, (1-(5-chloro-2-hydroxyphenyl)-3-(4-(trifluoromethyl)phenyl)-1 H-1,2,4-triazol-5(4 H)-one)... -
- CITED
-
- Close
- SHARE
-
- Close
